Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or   Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia   (AML) - Real-World Data from Two German Academic Centers

Titel:: Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers
Dokumenttyp:: Meeting Abstract
Autor(en):: Schmalbrock, Laura K.; Braitsch, Krischan; Jung, Paul; Bumeder, Irmgard; Kiewe, Philipp; Westermann, Joerg; Bullinger, Lars; Keller, Ulrich; Bassermann, Florian; Kroenke, Jan; Rieger, Kathrin; Goetze, Katharina S.
Zeitschriftentitel:: Blood
Jahr:: 2021
Band / Volume:: 138 Suppl 1
Volltext / DOI:: doi:10.1182/blood-2021-150943
Print-ISSN:: 0006-4971
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: